Economic analyses in cardiac electrophysiology: From clinical efficacy to cost utility

Maria Hee Jung Park Frausing; Jens Cosedis Nielsen; Caroline Louise Westergaard; Christian Gerdes; Jakob Kjellberg; Giuseppe Boriani; Mads Brix Kronborg

doi:10.1093/europace/euae031

Economic analyses in cardiac electrophysiology: From clinical efficacy to cost utility

Maria Hee Jung Park Frausing, Jens Cosedis Nielsen, Caroline Louise Westergaard, Christian Gerdes, Jakob Kjellberg, Giuseppe Boriani, Mads Brix Kronborg

Department of Clinical Medicine - The Department of Cardiological Medicine B

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Review › Research › peer-review

1 Citation (Scopus)

Abstract

Cardiac electrophysiology is an evolving field that relies heavily on costly device- and catheter-based technologies. An increasing number of patients with heart rhythm disorders are becoming eligible for cardiac interventions, not least due to the rising prevalence of atrial fibrillation and increased longevity in the population. Meanwhile, the expansive costs of healthcare face finite societal resources, and a cost-conscious approach to new technologies is critical. Cost-effectiveness analyses support rational decision-making in healthcare by evaluating the ratio of healthcare costs to health benefits for competing therapies. They may, however, be subject to significant uncertainty and bias. This paper aims to introduce the basic concepts, framework, and limitations of cost-effectiveness analyses to clinicians including recent examples from clinical electrophysiology and device therapy.

Original language	English
Article number	euae031
Journal	Europace
Volume	26
Issue	2
ISSN	1099-5129
DOIs	https://doi.org/10.1093/europace/euae031
Publication status	Published - Feb 2024

Keywords

Antibacterial envelope
Cardiac electrophysiology
Cardiac implantable electronic devices
Cost utility
Cost-effectiveness analysis
Early rhythm control
Economy
Quality-adjusted life year
Quality-Adjusted Life Years
Humans
Treatment Outcome
Health Care Costs
Cost-Benefit Analysis
Atrial Fibrillation/diagnosis
Electrophysiologic Techniques, Cardiac

Access to Document

10.1093/europace/euae031Licence: CC BY-NC

Cite this

@article{ec324ab15f64472ba9a105417b1c3298,

title = "Economic analyses in cardiac electrophysiology: From clinical efficacy to cost utility",

abstract = "Cardiac electrophysiology is an evolving field that relies heavily on costly device- and catheter-based technologies. An increasing number of patients with heart rhythm disorders are becoming eligible for cardiac interventions, not least due to the rising prevalence of atrial fibrillation and increased longevity in the population. Meanwhile, the expansive costs of healthcare face finite societal resources, and a cost-conscious approach to new technologies is critical. Cost-effectiveness analyses support rational decision-making in healthcare by evaluating the ratio of healthcare costs to health benefits for competing therapies. They may, however, be subject to significant uncertainty and bias. This paper aims to introduce the basic concepts, framework, and limitations of cost-effectiveness analyses to clinicians including recent examples from clinical electrophysiology and device therapy.",

keywords = "Antibacterial envelope, Cardiac electrophysiology, Cardiac implantable electronic devices, Cost utility, Cost-effectiveness analysis, Early rhythm control, Economy, Quality-adjusted life year, Quality-Adjusted Life Years, Humans, Treatment Outcome, Health Care Costs, Cost-Benefit Analysis, Atrial Fibrillation/diagnosis, Electrophysiologic Techniques, Cardiac",

author = "Frausing, {Maria Hee Jung Park} and Nielsen, {Jens Cosedis} and Westergaard, {Caroline Louise} and Christian Gerdes and Jakob Kjellberg and Giuseppe Boriani and Kronborg, {Mads Brix}",

note = "{\textcopyright} The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology.",

year = "2024",

month = feb,

doi = "10.1093/europace/euae031",

language = "English",

volume = "26",

journal = "Europace",

issn = "1099-5129",

publisher = "Oxford University Press",

number = "2",

}

TY - JOUR

T1 - Economic analyses in cardiac electrophysiology

T2 - From clinical efficacy to cost utility

AU - Frausing, Maria Hee Jung Park

AU - Nielsen, Jens Cosedis

AU - Westergaard, Caroline Louise

AU - Gerdes, Christian

AU - Kjellberg, Jakob

AU - Boriani, Giuseppe

AU - Kronborg, Mads Brix

N1 - © The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology.

PY - 2024/2

Y1 - 2024/2

N2 - Cardiac electrophysiology is an evolving field that relies heavily on costly device- and catheter-based technologies. An increasing number of patients with heart rhythm disorders are becoming eligible for cardiac interventions, not least due to the rising prevalence of atrial fibrillation and increased longevity in the population. Meanwhile, the expansive costs of healthcare face finite societal resources, and a cost-conscious approach to new technologies is critical. Cost-effectiveness analyses support rational decision-making in healthcare by evaluating the ratio of healthcare costs to health benefits for competing therapies. They may, however, be subject to significant uncertainty and bias. This paper aims to introduce the basic concepts, framework, and limitations of cost-effectiveness analyses to clinicians including recent examples from clinical electrophysiology and device therapy.

AB - Cardiac electrophysiology is an evolving field that relies heavily on costly device- and catheter-based technologies. An increasing number of patients with heart rhythm disorders are becoming eligible for cardiac interventions, not least due to the rising prevalence of atrial fibrillation and increased longevity in the population. Meanwhile, the expansive costs of healthcare face finite societal resources, and a cost-conscious approach to new technologies is critical. Cost-effectiveness analyses support rational decision-making in healthcare by evaluating the ratio of healthcare costs to health benefits for competing therapies. They may, however, be subject to significant uncertainty and bias. This paper aims to introduce the basic concepts, framework, and limitations of cost-effectiveness analyses to clinicians including recent examples from clinical electrophysiology and device therapy.

KW - Antibacterial envelope

KW - Cardiac electrophysiology

KW - Cardiac implantable electronic devices

KW - Cost utility

KW - Cost-effectiveness analysis

KW - Early rhythm control

KW - Economy

KW - Quality-adjusted life year

KW - Quality-Adjusted Life Years

KW - Humans

KW - Treatment Outcome

KW - Health Care Costs

KW - Cost-Benefit Analysis

KW - Atrial Fibrillation/diagnosis

KW - Electrophysiologic Techniques, Cardiac

UR - http://www.scopus.com/inward/record.url?scp=85184807062&partnerID=8YFLogxK

U2 - 10.1093/europace/euae031

DO - 10.1093/europace/euae031

M3 - Review

C2 - 38289720

SN - 1099-5129

VL - 26

JO - Europace

JF - Europace

IS - 2

M1 - euae031

ER -

Economic analyses in cardiac electrophysiology: From clinical efficacy to cost utility

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this